Non-steroidal anti-inflammatory drug for pulmonary administration: Design and investigation of ketoprofen lysinate fine dry powders-Reference-Cited by-同舟云学术

Non-steroidal anti-inflammatory drug for pulmonary administration: Design and investigation of ketoprofen lysinate fine dry powders

Published:2013-05 Issue:1 Volume:448 Page:198-204
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Stigliani Mariateresa,Aquino Rita P.,Del Gaudio Pasquale,Mencherini Teresa,Sansone Francesca,Russo Paola

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference27 articles.

1. Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells;Aquino;Int. J. Pharm.,2012

2. Lower airway inflammation in infants with cystic fibrosis detected by newborn screening;Armstrong;Pediatr. Pulmonol.,2005

3. Randomised controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis;Balfour-Lynn;Arch. Dis. Child.,1997

4. The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis;Balough;Pediatr. Pulmonol.,1995

5. State of the art: why do the lungs of patients with cystic fibrosis become infected and why cannot they clear the infection?;Chmiel;Respir. Res.,2003

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preparation of microspheres with sustained ketoprofen release by electrospray for the treatment of aseptic inflammation;Frontiers in Bioengineering and Biotechnology;2024-07-19

2. Development and characterization of nintedanib inhalable powders as a potential pulmonary fibrosis treatment;Journal of Drug Delivery Science and Technology;2024-02

3. A Novel Combined Dry Powder Inhaler Comprising Nanosized Ketoprofen-Embedded Mannitol-Coated Microparticles for Pulmonary Inflammations: Development, In Vitro–In Silico Characterization, and Cell Line Evaluation;Pharmaceuticals;2024-01-07

4. Flogomicina: A Natural Antioxidant Mixture as an Alternative Strategy to Reduce Biofilm Formation;Life;2023-04-13

5. Coprecipitation of Class II NSAIDs with Polymers for Oral Delivery;Polymers;2023-02-15